Veillette H. In Brief: Laboratory and clinical monitoring requirements for JAK inhibitors. Can Dermatol Today [Internet]. 2023 Mar. 1 [cited 2024 Nov. 23];4(1):20–22. Available from: https://canadiandermatologytoday.com/article/view/4-1-veillette